fullerene c60 has been researched along with gadolinium in 80 studies
Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (gadolinium) | Trials (gadolinium) | Recent Studies (post-2010) (gadolinium) |
---|---|---|---|---|---|
3,806 | 5 | 2,170 | 13,838 | 519 | 6,282 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 19 (23.75) | 29.6817 |
2010's | 58 (72.50) | 24.3611 |
2020's | 3 (3.75) | 2.80 |
Authors | Studies |
---|---|
Kanazawa, Y; Kato, H; Mikawa, M; Okumura, M; Shinohara, H; Yokawa, T | 1 |
Bolskar, RD; Borel, A; González, G; Helm, L; Merbach, AE; Sitharaman, B; Tóth, E; Wilson, LJ | 1 |
Asokan, S; Bolskar, RD; Helm, L; Laus, S; Merbach, AE; Sitharaman, B; Tóth, E; Wilson, LJ; Wong, MS | 1 |
Amos, TM; Cadorette, VR; Phillips, JP; Reid, JE; Stephen, RR; Stevenson, S | 1 |
Miyamoto, A; Okimoto, H; Shibamoto, Y; Shinohara, H | 1 |
Chai, Z; Chen, C; Chen, Z; Fang, X; Gao, Y; Li, B; Li, Y; Ma, B; Meng, H; Sun, J; Tang, J; Wan, L; Wang, J; Xing, G; Ye, C; Yu, H; Yuan, H; Zhao, Y; Zhu, C | 1 |
Iijima, S; Sato, Y; Suenaga, K; Urita, K; Yumura, T | 1 |
Han, HB; Pei, XL; Shu, CY; Wang, CR; Xiang, JF; Zhang, EY; Zhu, CF | 1 |
Liu, J; Murata, K; Nitta, N; Ohta, S; Sonoda, A; Tabata, Y; Yamada, M; Yamamoto, M | 1 |
Chen, D; Chu, W; Dunsch, L; Gao, B; Hu, T; Liu, L; Luo, Y; Marcelli, A; Wang, C; Wu, Z | 1 |
Hartman, KB; Wilson, LJ | 1 |
Athans, AJ; Balch, AL; Beavers, CM; Chancellor, CJ; Chaur, MN; Dorn, HC; Echegoyen, L; Holloway, BC; Melin, F; Olmstead, MM; Walker, K; Zuo, T | 1 |
Bolskar, RD | 1 |
Garbow, JR; Kepley, CL; Kumar, K; Lenk, RP; MacFarland, DK; Walker, KL; Wilson, SR | 1 |
Gao, B; Luo, Y; Wu, Z | 1 |
Chen, C; Fu, PP; Gao, X; Lao, F; Liang, XJ; Meng, J; Sun, B; Wang, PC; Xing, G; Yin, JJ; Zhao, Y | 1 |
Akasaka, T; Ishitsuka, MO; Kato, T; Kono, T; Liu, MT; Maeda, Y; Mizorogi, N; Nagase, S; Nakahodo, T; Nikawa, H; Slanina, Z; Takematsu, Y; Tsuchiya, T; Wakahara, T; Yamamoto, K; Yoza, K | 1 |
Balch, AL; Che, Y; Jin, H; Liu, Z; Lu, C; Olmstead, MM; Yang, H | 1 |
Chen, Z; Corwin, FD; Dorn, HC; Esker, AR; Fatouros, PP; Gibson, HW; Reid, JE; Shu, C; Sim, JH; Sun, M; Wang, C; Xu, W; Zhang, J | 1 |
Guo, H; Hou, W; Li, Y; Oppenheim, JJ; Tewary, P; Xing, G; Yang, D; Zhang, N; Zhao, Y | 1 |
Cai, T; Chen, ZJ; Corwin, FD; Dorn, HC; Fatouros, PP; Gibson, HW; Long, GL; Owens, LS; Reid, J; Shu, C; Zhang, J | 1 |
Baeuerle, T; Bock, M; Braun, K; Dunsch, L; Pipkorn, R; Waldeck, W; Wiessler, M; Yang, S | 1 |
Chang, X; Fang, X; Jing, L; Xing, G; Yuan, H; Zhang, M; Zhao, Y; Zhu, C | 1 |
Chen, C; Gao, Y; Ge, C; Li, B; Li, W; Li, Y; Liu, Y; Sun, B; Zhou, G | 1 |
Chen, C; Jia, L; Liang, XJ; Meng, J; Wang, DL; Wang, PC | 1 |
Chen, C; Gao, Y; Ge, C; Hu, W; Jiao, F; Li, B; Li, W; Li, Y; Liu, Y; Qu, Y; Zhou, G | 1 |
Matson, ML; Wilson, LJ | 1 |
Nie, G; Sun, B; Zhang, L; Zhang, W; Zhao, B; Zhao, Y | 1 |
Burke, BG; Champion, H; Dixon, C; Dorn, HC; Fu, W; Fuhrer, T; Furukawa, K; Ge, J; Harich, K; Kato, T; Mahaney, JE; Shu, C; Walker, K; Williams, KA; Zhang, J | 1 |
Dong, J; Guo, X; Hao, J; Ibrahim, K; Qian, H; Qiu, X; Sun, B; Wang, J; Xing, G; Yang, S; Yuan, B; Yuan, H; Zhang, H; Zhang, J; Zhao, S; Zhao, Y | 1 |
Gao, X; Jia, L; Liang, X; Lu, J; Meng, J; Wang, PC; Wang, Y; Xing, J; Zhao, Y | 1 |
Cao, RJ; Gao, WY; He, L; Li, LS; Nagase, S; Yang, T; Zhao, X; Zheng, JJ | 1 |
Osuna, S; Poblet, JM; Rodríguez-Fortea, A; Solà, M; Swart, M; Valencia, R | 1 |
Chen, C; Huynh, T; Kang, SG; Liu, Y; Meng, H; Sun, B; Xing, G; Yang, P; Zhao, L; Zhao, Y; Zhou, G; Zhou, R | 1 |
Chen, X; Liang, X; Meng, J; Zhao, Y | 1 |
Li, C; Li, F; Li, X; Tao, S; Xu, L | 1 |
Cao, W; Hao, X; Liang, XJ; Liu, J; Meng, J; Sun, B; Xue, X; Yang, K; Zhang, J; Zhao, J; Zhao, Y | 1 |
Echegoyen, L; Mulet-Gas, M; Poblet, JM; Rodríguez-Fortea, A | 1 |
Huynh, T; Kang, SG; Zhou, R | 1 |
Adiseshaiah, P; Bernardo, M; Brooks, DB; Dellinger, A; Dobrovolskaia, M; Ileva, L; Kepley, C; MacFarland, D; McNeil, S; Patri, AK; Stern, S; Zhou, Z | 1 |
Kang, SG; Li, J; Pan, J; Song, Y; Wang, F; Xing, G; Yin, X; Zhang, M; Zhao, L; Zhao, Y; Zhou, R | 1 |
Alegret, N; Poblet, JM; Rodríguez-Fortea, A; Salvadó, P | 1 |
Gao, F; Pyykkö, I; Shu, C; Wang, C; Wang, Y; Zhen, M; Zheng, J; Zou, J | 1 |
Balch, AL; Bearden, DW; Bowles, FL; Dixon, C; Dorn, HC; Fuhrer, T; Harich, K; Helm, RF; Olmstead, MM; Ray, WK; Ye, Y; Zhang, J | 1 |
Chang, Y; He, R; Jin, J; Li, J; Song, Y; Xing, G; Yin, X; Zhang, M; Zhao, J; Zhao, L; Zhao, Y | 1 |
Balasubramaniam, S; Chen, Y; Davis, RM; Dorn, HC; Hobart, DB; LaConte, SM; Li, T; Madsen, LA; Morris, JR; Pregot, C; Wi, S; Ye, Y; Yee, GT; Zhang, J; Zhang, Y | 1 |
Cao, W; Li, LM; Li, Q; Meng, J; Qiu, Y; Sun, B; Wang, L | 1 |
Horiguchi, Y; Koka, M; Matsumura, A; Nagasaki, Y; Nakai, K; Satoh, T; Shirakawa, M; Yamamoto, T; Yamamoto, Y | 1 |
Balch, AL; Ghiassi, KB; Olmstead, MM | 1 |
Chang, Y; Chen, K; He, R; Jin, J; Li, J; Song, Y; Sun, B; Wang, Y; Xing, G; Zhang, M | 1 |
Araya-Secchi, R; Huynh, T; Kang, SG; Wang, B; Wang, D; Zhou, R | 1 |
Arvola, KD; Fahim, M; Field, JS; Martin, BR; Rottinger, KA; Stevenson, S | 1 |
Aroua, S; Bölter, MF; Garcia-Borràs, M; Osuna, S; Yamakoshi, Y | 1 |
Dai, X; Gao, Y; Wang, Z; Xin, M; Zhou, R | 1 |
Bai, R; Chen, C; Chen, Z; Dong, J; Gao, X; Li, H; Liu, S; Liu, Y; Lobie, PE; Lu, X; Qian, P; Sun, B; Tang, J; Wang, L; Wicha, MS; Wu, Q; Zhang, H; Zhang, W; Zhang, X; Zhao, F; Zhao, Y; Zhu, T | 1 |
Ai, H; Deng, SL; Gao, J; Sun, C; Tang, X; Wang, L; Wu, C; Zhou, Z; Zhu, X | 1 |
Balogh, LP | 1 |
Bakshi, KS; Chen, Y; Davis, RM; Dorn, HC; Eltahir, A; Karolyi, DR; Kiselev, B; LaConte, SM; Li, T; Madsen, LA; Morris, JR; Murphy, S; Sheng, Z; Zhang, J; Zhang, Y; Zhu, J | 1 |
Chen, C; Guo, M; Huynh, T; Kang, SG; Lu, Y; Pan, Y; Wang, L; Yang, Z; Zhao, Y; Zhou, R | 1 |
Cao, G; Chen, J; Du, S; Huang, M; Pan, J; Qin, Z | 1 |
Bai, R; Chen, C; Chen, Z; Dong, J; Liu, J; Liu, Y; Miao, Q; Sun, B; Tang, J; Wang, L; Zhao, Y; Zhou, H | 1 |
Chen, D; Guan, M; Guan, X; Han, H; Shu, C; Wang, C; Zhang, Y; Zhen, M; Zou, T | 1 |
Gao, X; Gao, XJ; Jang, J; Wu, G | 1 |
Guan, M; Li, J; Shu, C; Wang, C; Wang, T; Zhao, F; Zhen, M | 1 |
Ding, M; Dorn, HC; Jin, L; LaConte, SM; Li, T; Li, X; Nacey, N; Rodríguez-Corrales, J; Weiss, DB; Xiao, L; Yang, J | 1 |
Deng, R; Guan, M; Guo, J; Jia, W; Li, J; Li, X; Lu, Z; Shu, C; Sun, L; Wang, C; Yu, T; Zhang, Y; Zhen, M; Zhou, Y; Zou, T | 1 |
Ding, M; Dorn, HC; Jin, L; LaConte, L; Li, T; Li, X; Xiao, L; Yang, J; Zhou, Z | 1 |
Li, J; Sun, B; Wu, Z; Xing, X; Zhao, Y | 1 |
Cui, R; Dong, J; Guo, X; Huang, H; Li, C; Liu, B; Sun, B; Xu, B; Yang, S; Yao, H; Zhang, L | 1 |
Chen, C; Han, Z; Lu, ZR; Roelle, S; Schiemann, WP; Wu, X | 1 |
Deng, R; Guan, M; Li, J; Li, X; Lu, Z; Shu, C; Wang, C; Xu, H; Yu, T; Zhang, Y; Zhen, M; Zhou, Y; Zou, T | 1 |
Chen, SH; Kang, SG; Luo, J; Zhou, R | 1 |
Cheng, W; Gao, J; Guo, M; Hu, W; Liu, J; Miao, QR; Tang, J; Wang, P; Xiao, Y | 1 |
Chen, X; Chen, ZY; Fu, X; Jacobson, O; Liu, Y; Shen, Z; Wang, S; Wang, Z; Zhou, Z | 1 |
Jia, W; Li, J; Ma, H; Wang, C; Yu, T; Zhen, M; Zhou, Y | 1 |
Chen, L; Chen, Z; Gu, Z; Li, J; Yan, L; Zhang, A; Zhao, F | 1 |
Chen, L; Chen, Z; Gu, Z; Li, J; Su, H; Yan, L; Zhang, A; Zhao, F; Zhao, Y | 1 |
Cho, SH; Kim, JB; Krishnan, S; Mackeyev, Y; Raghuram, S | 1 |
Chang, L; Liu, S; Meng, X; Plant, LD; Su, J; Wang, X; Wu, C; Yang, N | 1 |
Grebowski, J; Litwinienko, G | 1 |
9 review(s) available for fullerene c60 and gadolinium
Article | Year |
---|---|
Carbon nanostructures as a new high-performance platform for MR molecular imaging.
Topics: Carbon; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Chemical; Nanoparticles; Nanostructures; Nanotechnology; Nanotubes; Nanotubes, Carbon; Neoplasms | 2007 |
Gadofullerene MRI contrast agents.
Topics: Contrast Media; Drug Carriers; Fullerenes; Gadolinium; Image Enhancement; Magnetic Resonance Imaging; Nanomedicine; Nanostructures | 2008 |
Nanotechnology and MRI contrast enhancement.
Topics: Animals; Cell Line, Tumor; Contrast Media; Ferric Compounds; Fullerenes; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Nanotechnology; Nanotubes, Carbon; Particle Size | 2010 |
Biological characterizations of [Gd@C82(OH)22]n nanoparticles as fullerene derivatives for cancer therapy.
Topics: Fullerenes; Gadolinium; Humans; Metal Nanoparticles; Nanocapsules; Neoplasms | 2013 |
Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents.
Topics: Contrast Media; Fullerenes; Gadolinium; Magnetic Resonance Imaging | 2014 |
Caging cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Delivery Systems; Female; Fullerenes; Gadolinium; Humans | 2015 |
A Novel Drug Design Strategy: An Inspiration from Encaging Tumor by Metallofullerenol Gd@C
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Design; Fullerenes; Gadolinium; Humans; Molecular Dynamics Simulation; Nanomedicine; Nanoparticles | 2019 |
The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy.
Topics: Contrast Media; Coordination Complexes; Fullerenes; Gadolinium; Humans; Nanomedicine; Neoplasms; Neoplastic Stem Cells; Reactive Oxygen Species; Tumor Microenvironment | 2019 |
Metallofullerenols in biomedical applications.
Topics: Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 2022 |
71 other study(ies) available for fullerene c60 and gadolinium
Article | Year |
---|---|
Evaluation of water-soluble metallofullerenes as MRI contrast agents.
Topics: Animals; Carbon; Chromatography, High Pressure Liquid; Contrast Media; Female; Fullerenes; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Mice; Nuclear Magnetic Resonance, Biomolecular; Protons; Solubility; Tissue Distribution | 2002 |
Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
Topics: Contrast Media; Electron Spin Resonance Spectroscopy; Fullerenes; Gadolinium; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Oxygen Isotopes; Protons; Solubility; Water | 2005 |
Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH(2))](10).
Topics: Contrast Media; Fullerenes; Gadolinium; Hydroxides; Organometallic Compounds; Salts; Water | 2005 |
Synthesis and purification of a metallic nitride fullerene bisadduct: exploring the reactivity of Gd3N@C80.
Topics: Fullerenes; Gadolinium; Molecular Structure; Nitrogen; Organometallic Compounds; Time Factors | 2005 |
Development of water-soluble metallofullerenes as X-ray contrast media.
Topics: Contrast Media; Dysprosium; Erbium; Europium; Fullerenes; Gadolinium; Humans; Lanthanoid Series Elements; Lutetium; Solubility; Tomography, X-Ray Computed; Water | 2006 |
Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice.
Topics: Animals; Antioxidants; Blood Coagulation; Carcinoma, Hepatocellular; Female; Fullerenes; Gadolinium; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred Strains; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Tissue Distribution; Xenograft Model Antitumor Assays | 2006 |
Gate effect of vacancy-type defect of fullerene cages on metal-atom migrations in metallofullerenes.
Topics: Calcium; Carbon; Fullerenes; Gadolinium; Models, Chemical; Quantum Theory | 2006 |
Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.
Topics: Contrast Media; Fullerenes; Gadolinium; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Organometallic Compounds; Particle Size; Solubility; Water | 2006 |
Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Cobalt Radioisotopes; Contrast Media; Excipients; Fullerenes; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Mice; Neoplasm Transplantation; Neoplasms; Pentetic Acid; Photochemotherapy; Polyethylene Glycols; Superoxides | 2007 |
The structural determination of endohedral metallofullerene Gd@C(82) by XANES.
Topics: Fullerenes; Gadolinium; Models, Molecular; Molecular Structure; Spectrum Analysis; X-Rays | 2008 |
New egg-shaped fullerenes: non-isolated pentagon structures of Tm3N@C(s)(51 365)-C84 and Gd3N@C(s)(51 365)-C84.
Topics: Crystallography, X-Ray; Fullerenes; Gadolinium; Models, Molecular; Nitrogen; Thulium | 2008 |
Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast.
Topics: Animals; Contrast Media; Fullerenes; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Molecular Structure; Organ Specificity | 2008 |
A density functional theory study of shake-up satellites in photoemission of carbon fullerenes and nanotubes.
Topics: Electrons; Fullerenes; Gadolinium; Models, Chemical; Models, Molecular; Molecular Conformation; Nanotubes, Carbon; Photons; Quantum Theory | 2008 |
Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Female; Fullerenes; Gadolinium; Humans; Lipid Peroxidation; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Does Gd@C82 have an anomalous endohedral structure? Synthesis and single crystal X-ray structure of the carbene adduct.
Topics: Adamantane; Crystallography, X-Ray; Fullerenes; Gadolinium; Methane; Molecular Structure; Organometallic Compounds | 2008 |
Detection of a family of gadolinium-containing endohedral fullerenes and the isolation and crystallographic characterization of one member as a metal-carbide encapsulated inside a large fullerene cage.
Topics: Carbon; Chlorobenzenes; Chromatography; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Fullerenes; Gadolinium; Graphite; Ions; Magnetic Resonance Imaging; Mass Spectrometry; Metals; Software; Spectrophotometry; X-Ray Diffraction | 2008 |
Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity.
Topics: Animals; Contrast Media; Diffusion; Female; Fullerenes; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Peroxides; Protons; Rats; Solubility; Water | 2009 |
[Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses.
Topics: Animals; Antigens; Antineoplastic Agents; Cell Differentiation; Dendritic Cells; Fullerenes; Gadolinium; Humans; Interleukin-6; Mice; Nanoparticles; Organometallic Compounds; Th1 Cells | 2010 |
High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.
Topics: Animals; Brain Neoplasms; Contrast Media; Disease Models, Animal; Fullerenes; Gadolinium; Magnetic Resonance Imaging; Models, Molecular; Molecular Weight; Neoplasms, Experimental; Nitrogen; Organometallic Compounds; Particle Size; Polyethylene Glycols; Rats; Tissue Distribution | 2010 |
Gain of a 500-fold sensitivity on an intravital MR contrast agent based on an endohedral gadolinium-cluster-fullerene-conjugate: a new chance in cancer diagnostics.
Topics: Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 2010 |
Transmembrane delivery of aggregated [Gd@C82(OH)22]n nanoparticles.
Topics: Animals; Biological Transport; Cell Membrane Permeability; Cytoplasm; Drug Delivery Systems; Erythrocyte Membrane; Erythrocytes; Fullerenes; Gadolinium; Hydrophobic and Hydrophilic Interactions; Metal Nanoparticles; Mice; Microscopy, Atomic Force; Particle Size; Scattering, Small Angle; X-Ray Diffraction | 2010 |
Subcellular distribution of polyhydroxylated metallofullerene Gd@C82(OH)22 in different tissues of tumor-bearing mice.
Topics: Animals; Biological Availability; Centrifugation; Female; Fullerenes; Gadolinium; Intracellular Space; Liver Neoplasms, Experimental; Mass Spectrometry; Mice; Nanocomposites; Organometallic Compounds; Tissue Distribution; Transplantation, Heterologous | 2010 |
Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.
Topics: Animals; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Nanoparticles; Nanotechnology; Radiopharmaceuticals; Toxicity Tests | 2010 |
Modulation of oxidative stress by functionalized fullerene materials in the lung tissues of female C57/BL mice with a metastatic Lewis lung carcinoma.
Topics: Animals; Carcinoma, Lewis Lung; Female; Fullerenes; Gadolinium; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Lung; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Organometallic Compounds; Oxidative Stress; Superoxide Dismutase | 2010 |
Biosafety assessment of Gd@C82(OH)22 nanoparticles on Caenorhabditis elegans.
Topics: Animals; Body Size; Caenorhabditis elegans; Fullerenes; Gadolinium; Heat-Shock Response; Kaplan-Meier Estimate; Materials Testing; Metal Nanoparticles; Oviposition | 2011 |
Gd2@C79N: isolation, characterization, and monoadduct formation of a very stable heterofullerene with a magnetic spin state of S = 15/2.
Topics: Electron Spin Resonance Spectroscopy; Fullerenes; Gadolinium; Magnetics | 2011 |
Structural change of metallofullerene: an easier thermal decomposition.
Topics: Carbon; Fullerenes; Gadolinium; Temperature | 2011 |
Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Crystallization; Epigenesis, Genetic; Fullerenes; Gadolinium; Humans; Nanocapsules; Nanomedicine; Nanostructures; Particle Size; Treatment Outcome | 2011 |
Violating the isolated pentagon rule (IPR): endohedral non-IPR C98 cages of Gd2@C98.
Topics: Fullerenes; Gadolinium; Isomerism; Models, Molecular; Quantum Theory; Thermodynamics | 2012 |
Full exploration of the Diels-Alder cycloaddition on metallofullerenes M3N@C80 (M = Sc, Lu, Gd): the D(5h) versus I(h) isomer and the influence of the metal cluster.
Topics: Cyclization; Fullerenes; Gadolinium; Isomerism; Kinetics; Lutetium; Metals; Models, Molecular; Scandium | 2012 |
Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine.
Topics: Animals; Catalytic Domain; Drug Design; Extracellular Matrix; Fullerenes; Gadolinium; Humans; Hydrogen Bonding; Ions; Ligands; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms; Zinc | 2012 |
Molecular structure, electronic property and vibrational spectroscopy of C24-glycine and Gd@C24-glycine complexes.
Topics: Coordination Complexes; Fullerenes; Gadolinium; Glycine; Models, Molecular; Quantum Theory; Spectrophotometry, Infrared; Thermodynamics | 2012 |
Metallofullerene nanoparticles promote osteogenic differentiation of bone marrow stromal cells through BMP signaling pathway.
Topics: Animals; Bone Morphogenetic Proteins; Cells, Cultured; Female; Fullerenes; Gadolinium; Materials Testing; Mesenchymal Stem Cells; Metal Nanoparticles; Mice; Mice, Inbred ICR; Osteoblasts; Osteogenesis; Rats; Signal Transduction | 2013 |
Relevance of thermal effects in the formation of endohedral metallofullerenes: the case of Gd3N@C(s)(39663)-C82 and other related systems.
Topics: Fullerenes; Gadolinium; Nitrogen; Quantum Theory; Temperature | 2013 |
Metallofullerenol Gd@C₈₂(OH)₂₂ distracts the proline-rich-motif from putative binding on the SH3 domain.
Topics: Amino Acid Sequence; Binding Sites; Binding, Competitive; Fullerenes; Gadolinium; Humans; Metal Nanoparticles; Molecular Dynamics Simulation; Molecular Sequence Data; Proline-Rich Protein Domains; Protein Binding; src Homology Domains | 2013 |
A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Topics: Animals; Complement Activation; Contrast Media; Fullerenes; Gadolinium; Hemolysis; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Mice; Microscopy, Atomic Force; Molecular Dynamics Simulation; Nanoparticles; Organometallic Compounds; Platelet Aggregation; Spectrophotometry, Atomic | 2013 |
Impacts of fullerene derivatives on regulating the structure and assembly of collagen molecules.
Topics: Collagen; Coordination Complexes; Fullerenes; Gadolinium; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation | 2013 |
Bingel-Hirsch addition on non-isolated-pentagon-rule Gd3N@C2n (2n = 82 and 84) metallofullerenes: products under kinetic control.
Topics: Coordination Complexes; Fullerenes; Gadolinium; Isomerism; Kinetics; Molecular Structure | 2013 |
Multifunctional nanoprobe for MRI/optical dual-modality imaging and radical scavenging.
Topics: Animals; Blood-Brain Barrier; Contrast Media; Coordination Complexes; Free Radical Scavengers; Fullerenes; Gadolinium; Humans; Liver; Magnetic Resonance Imaging; Mice; Nanostructures; Radiography; Rats; Reactive Oxygen Species; Tissue Distribution | 2013 |
A missing link in the transformation from asymmetric to symmetric metallofullerene cages implies a top-down fullerene formation mechanism.
Topics: Crystallography, X-Ray; Fullerenes; Gadolinium; Magnetic Resonance Spectroscopy; Molecular Structure; Solvents; Yttrium | 2013 |
Regulation on mechanical properties of collagen: enhanced bioactivities of metallofullerol.
Topics: Animals; Collagen Type I; Extracellular Matrix; Fullerenes; Gadolinium | 2014 |
Gd3N@C84(OH)x: a new egg-shaped metallofullerene magnetic resonance imaging contrast agent.
Topics: Contrast Media; Fullerenes; Gadolinium; Magnetic Resonance Imaging | 2014 |
Induction of apoptosis through ER stress and TP53 in MCF-7 cells by the nanoparticle [Gd@C82(OH)22]n: A systems biology study.
Topics: Apoptosis; Cell Proliferation; Endoplasmic Reticulum; Fullerenes; Gadolinium; Gene Regulatory Networks; Humans; MCF-7 Cells; Nanoparticles; Oligonucleotide Array Sequence Analysis; Stress, Physiological; Systems Biology; Transcriptome; Tumor Suppressor Protein p53 | 2014 |
Intra-tumor distribution of metallofullerene using micro-particle induced X-ray emission (PIXE).
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Fullerenes; Gadolinium; Mice; Mice, Inbred BALB C; Microspheres; Spectrometry, X-Ray Emission | 2014 |
Gd@C82(OH)22 nanoparticles constrain macrophages migration into tumor tissue to prevent metastasis.
Topics: Animals; Cell Communication; Cell Line; Cell Movement; Cell Size; Fullerenes; Gadolinium; Macrophages; Mice; Nanoparticles; Neoplasms, Experimental; Tumor Microenvironment | 2014 |
Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.
Topics: Amino Acid Sequence; Binding Sites; Catalytic Domain; Fullerenes; Gadolinium; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Models, Molecular; Molecular Sequence Data; Nanomedicine; Neoplasms; Protein Binding; Protein Conformation; Sequence Alignment; Signal Transduction | 2014 |
Tuning the selectivity of Gd3N cluster endohedral metallofullerene reactions with Lewis acids.
Topics: Amination; Chemical Precipitation; Fullerenes; Gadolinium; Lewis Acids; Silicon Dioxide | 2014 |
Endohedral metal-induced regioselective formation of bis-Prato adduct of Y3N@I(h)-C80 and Gd3N@I(h)-C80.
Topics: Fullerenes; Gadolinium; Kinetics; Nitrogen; Quantum Theory; Stereoisomerism; Yttrium | 2015 |
The ground state and electronic structure of Gd@C82: a systematic theoretical investigation of first principle density functionals.
Topics: Carbon; Electrons; Fullerenes; Gadolinium; Isomerism; Models, Chemical; Molecular Structure | 2014 |
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor.
Topics: Animals; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Female; Fullerenes; Gadolinium; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanomedicine; Nanostructures; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Transforming Growth Factor beta; Triple Negative Breast Neoplasms | 2015 |
A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent.
Topics: Animals; Contrast Media; Coordination Complexes; Fullerenes; Gadolinium; Heart; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Radiography; Rats; Rats, Sprague-Dawley | 2015 |
A New Interleukin-13 Amino-Coated Gadolinium Metallofullerene Nanoparticle for Targeted MRI Detection of Glioblastoma Tumor Cells.
Topics: Amination; Animals; Cell Line, Tumor; Contrast Media; Fullerenes; Gadolinium; Glioblastoma; Humans; Interleukin-13; Magnetic Resonance Imaging; Mice, Nude; Models, Molecular; Nanoparticles | 2015 |
Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Fullerenes; Gadolinium; GPI-Linked Proteins; Histone Deacetylase 1; Histone Deacetylases; Humans; Molecular Sequence Data; Nanoparticles; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Binding; Repressor Proteins; Trans-Activators | 2015 |
In-Plane Intermolecular Interaction Assisted Assembly and Modified Electronic States of Metallofullerene Gd@C₈₂.
Topics: Fullerenes; Gadolinium; Microscopy, Scanning Tunneling | 2015 |
Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Fullerenes; Gadolinium; Humans; Immunotherapy, Adoptive; Macrophages; Mice; Mitochondria; Nanoparticles; Neoplasm Metastasis; Neoplasms | 2016 |
Synergistic Effect of Human Serum Albumin and Fullerene on Gd-DO3A for Tumor-Targeting Imaging.
Topics: Animals; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Neoplasms; Organometallic Compounds; Serum Albumin | 2016 |
Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities.
Topics: Binding, Competitive; Fullerenes; Gadolinium; Humans; Ligands; Metals; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Thermodynamics; Tumor Necrosis Factor-alpha | 2016 |
Gd@C
Topics: Cell Line; Ethylenediamines; Fullerenes; Gadolinium; Humans; Hydrogen Peroxide; Nanoparticles; Reactive Oxygen Species; Water | 2016 |
Detecting Chronic Post-Traumatic Osteomyelitis of Mouse Tibia via an IL-13Rα2 Targeted Metallofullerene Magnetic Resonance Imaging Probe.
Topics: Amino Acid Sequence; Animals; Biomarkers; Chronic Disease; Female; Fullerenes; Gadolinium; Interleukin-13; Interleukin-13 Receptor alpha2 Subunit; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Models, Molecular; Nanoparticles; Osteomyelitis; RAW 264.7 Cells; Receptors, Interleukin-13; Tibia | 2017 |
Amino acid functionalized gadofullerene nanoparticles with superior antitumor activity via destruction of tumor vasculature in vivo.
Topics: Alanine; Animals; Antinematodal Agents; Cell Line, Tumor; Female; Fullerenes; Gadolinium; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic | 2017 |
Trimetallic Nitride Endohedral Fullerenes Carboxyl-Gd
Topics: Contrast Media; Fullerenes; Gadolinium; Inflammation; Oxidative Stress; Theranostic Nanomedicine | 2017 |
Metallofullerenol Inhibits Cellular Iron Uptake by Inducing Transferrin Tetramerization.
Topics: Biological Transport; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Fullerenes; Gadolinium; Humans; Iron; Nanomedicine; Organometallic Compounds; Structure-Activity Relationship; Transferrin | 2017 |
Study on the antigenicity of metallofullerenol: antibody production, characterization, and its enzyme immunoassay application.
Topics: Animals; Antibodies; Antibody Formation; Antibody Specificity; Cattle; Female; Fullerenes; Gadolinium; Hemocyanins; Immunoenzyme Techniques; Rabbits | 2017 |
Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer.
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Female; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; MCF-7 Cells; Mice; Precision Medicine; Triple Negative Breast Neoplasms | 2017 |
RF-assisted gadofullerene nanoparticles induces rapid tumor vascular disruption by down-expression of tumor vascular endothelial cadherin.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Blood Vessels; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Endothelium, Vascular; Fullerenes; Gadolinium; Hep G2 Cells; Heterografts; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Radio Waves | 2018 |
Charging nanoparticles: increased binding of Gd@C
Topics: Amino Acid Sequence; Binding Sites; Catalytic Domain; Fullerenes; Gadolinium; Humans; Hydrophobic and Hydrophilic Interactions; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Nanoparticles | 2018 |
Gd-Metallofullerenol nanoparticles cause intracellular accumulation of PDGFR-α and morphology alteration of fibroblasts.
Topics: Animals; Antineoplastic Agents; Cell Shape; Endosomes; Fibroblasts; Fullerenes; Gadolinium; Gene Expression Regulation; Metal Nanoparticles; Mice; NIH 3T3 Cells; Phosphorylation; rab5 GTP-Binding Proteins; Receptor, Platelet-Derived Growth Factor alpha; Signal Transduction | 2019 |
Gadolinium Metallofullerene-Based Activatable Contrast Agent for Tumor Signal Amplification and Monitoring of Drug Release.
Topics: Animals; Contrast Media; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fullerenes; Gadolinium; HeLa Cells; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Polymers; Tumor Microenvironment | 2019 |
Anti-apoptosis effect of amino acid modified gadofullerene via a mitochondria mediated pathway.
Topics: Alanine; Apoptosis; Cell Line; Coordination Complexes; Fullerenes; Gadolinium; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria | 2019 |
Synthesis and characterization of gadolinium-decorated [60]fullerene for tumor imaging and radiation sensitization.
Topics: Cell Line, Tumor; Chemistry Techniques, Synthetic; Fullerenes; Gadolinium; Humans; Molecular Imaging; Radiation-Sensitizing Agents; Solubility | 2021 |
The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C
Topics: Antineoplastic Agents; Fullerenes; Gadolinium; Humans; Neoplasms; Organometallic Compounds; Voltage-Dependent Anion Channel 1 | 2022 |